| Views | |
|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 290 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 3 | 17 | 2 | 1 | 3 | 10 | 0 |
| Views | |
|---|---|
| art_3A10.1186_2Fs13195-016-0189-7.pdf | 202 |
